Versor Investments’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Versor Investments’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-625,067	Closed	-$47M	–	995
2022 Q2	$47M	Buy	+625,067	New	+$27.8M	1.8%	20

Versor Investments's TPTX Position: Q3 2022 in Review

Versor Investments sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 625,067 shares — an estimated $47M sold.

Versor Investments first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $47M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Versor Investments reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Versor Investments sold 625,067 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $47M.
Versor Investments first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Versor Investments's Turning Point Therapeutics, Inc. Common Stock position peaked at $47M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Versor Investments's 13F filing for Q3 2022, filed 25 Oct 2022.